Chembio Diagnostics, Inc. (CEMI) financial statements (2020 and earlier)

Company profile

Business Address 555 WIRELESS BLVD.
HAUPPAUGE, NY 11788
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18134115510
Cash and cash equivalents18134115510
Receivables4723285
Inventory, net of allowances, customer advances and progress billings10843443
Inventory10843443
Prepaid expense and other current assets1
Other undisclosed current assets111111 
Total current assets:32281118131819
Noncurrent Assets
Finance lease, right-of-use asset0
Operating lease, right-of-use asset7
Property, plant and equipment6322232
Intangible assets, net (including goodwill)1093 01
Goodwill652    
Intangible assets, net (excluding goodwill)442 01 
Deposits noncurrent assets1111000
Other undisclosed noncurrent assets   0534
Total noncurrent assets:241262876
TOTAL ASSETS:56411721212524
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:6633354
Accounts payable341112 
Accrued liabilities111112 
Employee-related liabilities111111 
Other undisclosed accounts payable and accrued liabilities1     4
Deferred revenue0
Debt10  00 
Deferred revenue and credits00 0 
Contract with customer, liability0
Other undisclosed current liabilities     (0) 
Total current liabilities:6733354
Noncurrent Liabilities
Long-term debt and lease obligation2500    
Long-term debt, excluding current maturities1800    
Finance lease, liability0
Operating lease, liability7
Liabilities, other than long-term debt010    
Deferred tax liabilities, net10    
Deferred income tax liabilities0
Total noncurrent liabilities:2510    
Total liabilities:32843354
Stockholders' equity
Stockholders' equity attributable to parent24331317182020
Common stock0000000
Additional paid in capital95916361484847
Accumulated other comprehensive income000    
Accumulated deficit(72)(58)(50)(44)(30)(28)(27)
Total stockholders' equity:24331317182020
TOTAL LIABILITIES AND EQUITY:56411721212524

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues34332418242830
Revenue, net2418242830
Cost of revenue(22)(21)(13)(9)(14)(17)(17)
Cost of goods and services sold (21)(13)(9)(14)(17)(17)
Gross profit:1212118101112
Operating expenses(25)(41)(30)(16)(14)(12)(11)
Other undisclosed operating income 2113    
Operating income (loss):(13)(8)(6)(8)(4)(2)1
Nonoperating income (expense) 000(0)00
Investment income, nonoperating 0  000
Other nonoperating income  00   
Interest and debt expense(0) (0) (0) (0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(1) 0    
Income (loss) from continuing operations before equity method investments, income taxes:(14)(8)(6)(8)(4)(2)1
Other undisclosed income from continuing operations before income taxes    0 0
Income (loss) from continuing operations before income taxes:(14)(8)(6)(8)(4)(2)1
Income tax expense (benefit)100(6)10(0)
Net income (loss) available to common stockholders, diluted:(14)(8)(6)(13)(2)(1)1

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(14)(8)(6)(13)(2)(1)1
Comprehensive income (loss):(14)(8)(6)(13)(2)(1)1
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)(0)0    
Comprehensive income (loss), net of tax, attributable to parent:(14)(8)(6)(13)(2)(1)1

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: